There is no established treatment for medication-related osteonecrosis of the jaw (MRONJ). Advanced MRONJ of the maxilla dose not cure with conservative treatment, and progression may cause neurological symptoms. We herein report two cases in which MRONJ of the maxilla spread to the skull base despite conservative treatment, causing abducens paralysis in one case and hydrocephalus in the second. Case 1: A 50-year-old woman who received denosumab for 2 years for multiple bone metastases of breast cancer developed MRONJ in the left maxilla after tooth extraction. MRONJ of the maxillae can progress to the skull and may cause neurological symptoms. Abducens paralysis developed for MRONJ. Magnetic resonance images revealed narrowing of the internal carotid artery and necrosis of the sphenoid bone and clivus. Sequestrectomy was performed. Two weeks after surgery, abducens paralysis resolved. Magnetic resonance imaging 3 months after surgery showed improvement of internal carotid artery narrowing. Case 2: A 73year-old woman who received zoledronic acid for 2 years for multiple bone metastases of breast cancer developed MRONJ in the left maxilla that spread broadly despite conservative treatment. Sequestrectomy was planned, but the patient developed altered consciousness and a stiff neck; ventricular enlargement was observed on magnetic resonance images of the brain. We diagnosed hydrocephalus resulting from bacterial meningitis caused by MRONJ; ventricular drainage was performed. After drainage followed by 2 weeks of antibiotics, the sequestrum was removed. These cases suggest that some patients with maxillary MRONJ might not respond to conservative therapy and the need for early surgical intervention should be considered in order to reduce the risk of necrosis progressing and the associated infection spreading to the base of skull.Oral Surgery 13 (2020) 147--156.